These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 24295593)
1. A resourceful giant: APMV is able to interfere with the human type I interferon system. Silva LC; Almeida GM; Oliveira DB; Dornas FP; Campos RK; La Scola B; Ferreira PC; Kroon EG; Abrahão JS Microbes Infect; 2014 Mar; 16(3):187-95. PubMed ID: 24295593 [TBL] [Abstract][Full Text] [Related]
2. Mimiviruses and the Human Interferon System: Viral Evasion of Classical Antiviral Activities, But Inhibition By a Novel Interferon-β Regulated Immunomodulatory Pathway. Almeida GM; Silva LC; Colson P; Abrahao JS J Interferon Cytokine Res; 2017 Jan; 37(1):1-8. PubMed ID: 28079476 [TBL] [Abstract][Full Text] [Related]
3. Lack of evidence of mimivirus replication in human PBMCs. Abrahão J; Silva L; Oliveira D; Almeida G Microbes Infect; 2018 May; 20(5):281-283. PubMed ID: 29604428 [TBL] [Abstract][Full Text] [Related]
4. Amoebas as mimivirus bunkers: increased resistance to UV light, heat and chemical biocides when viruses are carried by amoeba hosts. Boratto PV; Dornas FP; Andrade KR; Rodrigues R; Peixoto F; Silva LC; La Scola B; Costa AO; de Almeida GM; Kroon EG; Abrahão JS Arch Virol; 2014 May; 159(5):1039-43. PubMed ID: 24271007 [TBL] [Abstract][Full Text] [Related]
5. Mimivirus Fibrils Are Important for Viral Attachment to the Microbial World by a Diverse Glycoside Interaction Repertoire. Rodrigues RA; dos Santos Silva LK; Dornas FP; de Oliveira DB; Magalhães TF; Santos DA; Costa AO; de Macêdo Farias L; Magalhães PP; Bonjardim CA; Kroon EG; La Scola B; Cortines JR; Abrahão JS J Virol; 2015 Dec; 89(23):11812-9. PubMed ID: 26378162 [TBL] [Abstract][Full Text] [Related]
6. Virucidal activity of chemical biocides against mimivirus, a putative pneumonia agent. Campos RK; Andrade KR; Ferreira PC; Bonjardim CA; La Scola B; Kroon EG; Abrahão JS J Clin Virol; 2012 Dec; 55(4):323-8. PubMed ID: 22947947 [TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus replication in mouse cells is restricted by IFN-dependent and -independent mechanisms. Nandakumar R; Finsterbusch K; Lipps C; Neumann B; Grashoff M; Nair S; Hochnadel I; Lienenklaus S; Wappler I; Steinmann E; Hauser H; Pietschmann T; Kröger A Gastroenterology; 2013 Dec; 145(6):1414-23.e1. PubMed ID: 23973921 [TBL] [Abstract][Full Text] [Related]
9. Type I interferon subtypes produced by human peripheral mononuclear cells from one normal donor stimulated by viral and non-viral inducing factors. Palmer P; Tovey MG; Raschilas F; Brassart L; Meritet JF; Porcher R; Lebon P Eur Cytokine Netw; 2007 Jun; 18(2):108-14. PubMed ID: 17594944 [TBL] [Abstract][Full Text] [Related]
10. Type I interferon signaling in systemic immune cells from patients with alcoholic cirrhosis and its association with outcome. Weiss E; Rautou PE; Fasseu M; Giabicani M; de Chambrun M; Wan J; Minsart C; Gustot T; Couvineau A; Maiwall R; Hurtado-Nedelec M; Pilard N; Lebrec D; Valla D; Durand F; de la Grange P; Monteiro RC; Paugam-Burtz C; Lotersztajn S; Moreau R J Hepatol; 2017 May; 66(5):930-941. PubMed ID: 28040548 [TBL] [Abstract][Full Text] [Related]
11. Hcmv-miR-UL112 attenuates NK cell activity by inhibition type I interferon secretion. Huang Y; Chen D; He J; Cai J; Shen K; Liu X; Yang X; Xu L Immunol Lett; 2015 Feb; 163(2):151-6. PubMed ID: 25530545 [TBL] [Abstract][Full Text] [Related]
12. Differential interferon pathway gene expression patterns in Rhabdomyosarcoma cells during Enterovirus 71 or Coxsackievirus A16 infection. Zhang W; Zhang L; Wu Z; Tien P Biochem Biophys Res Commun; 2014 May; 447(3):550-5. PubMed ID: 24735544 [TBL] [Abstract][Full Text] [Related]
13. Amoebae, Giant Viruses, and Virophages Make Up a Complex, Multilayered Threesome. Diesend J; Kruse J; Hagedorn M; Hammann C Front Cell Infect Microbiol; 2017; 7():527. PubMed ID: 29376032 [TBL] [Abstract][Full Text] [Related]
14. Growing a giant: evaluation of the virological parameters for mimivirus production. Abrahão JS; Boratto P; Dornas FP; Silva LC; Campos RK; Almeida GM; Kroon EG; La Scola B J Virol Methods; 2014 Oct; 207():6-11. PubMed ID: 24972367 [TBL] [Abstract][Full Text] [Related]
15. Gram-Positive Bacteria-Like DNA Binding Machineries Involved in Replication Initiation and Termination Mechanisms of Mimivirus. Akashi M; Takemura M Viruses; 2019 Mar; 11(3):. PubMed ID: 30884919 [TBL] [Abstract][Full Text] [Related]
16. Global transcriptional profiling demonstrates the combination of type I and type II interferon enhances antiviral and immune responses at clinically relevant doses. Tan H; Derrick J; Hong J; Sanda C; Grosse WM; Edenberg HJ; Taylor M; Seiwert S; Blatt LM J Interferon Cytokine Res; 2005 Oct; 25(10):632-49. PubMed ID: 16241862 [TBL] [Abstract][Full Text] [Related]
17. Acanthamoeba polyphaga mimivirus and other giant viruses: an open field to outstanding discoveries. Abrahão JS; Dornas FP; Silva LC; Almeida GM; Boratto PV; Colson P; La Scola B; Kroon EG Virol J; 2014 Jun; 11():120. PubMed ID: 24976356 [TBL] [Abstract][Full Text] [Related]
18. Antibody-dependent induction of type I interferons by poliovirus in human mononuclear blood cells requires the type II fcgamma receptor (CD32). Palmer P; Charley B; Rombaut B; Daëron M; Lebon P Virology; 2000 Dec; 278(1):86-94. PubMed ID: 11112484 [TBL] [Abstract][Full Text] [Related]
19. Interleukin-1- and type I interferon-dependent enhanced immunogenicity of an NYVAC-HIV-1 Env-Gag-Pol-Nef vaccine vector with dual deletions of type I and type II interferon-binding proteins. Delaloye J; Filali-Mouhim A; Cameron MJ; Haddad EK; Harari A; Goulet JP; Gomez CE; Perdiguero B; Esteban M; Pantaleo G; Roger T; Sékaly RP; Calandra T J Virol; 2015 Apr; 89(7):3819-32. PubMed ID: 25609807 [TBL] [Abstract][Full Text] [Related]
20. Treatment with type I interferons induces a regulatory T cell subset in peripheral blood mononuclear cells from multiple sclerosis patients. Pentón-Rol G; Cervantes-Llanos M; Cabrera-Gómez JA; Alonso-Ramírez R; Valenzuela-Silva C; Rodríguez-Lara R; Montero-Casimiro E; Bello-Rivero I; López-Saura P Int Immunopharmacol; 2008 Jun; 8(6):881-6. PubMed ID: 18442793 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]